{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T22:59:06Z","timestamp":1787353146694,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-024-08439-5","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T06:02:04Z","timestamp":1727416924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of methylene blue in refractory septic shock: study protocol for a multicenter, randomized, placebo-controlled trial"],"prefix":"10.1186","volume":"25","author":[{"given":"Jinxin","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6273-1667","authenticated-orcid":false,"given":"Zhifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"11","key":"8439_CR1","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063\u2013143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337.","journal-title":"Crit Care Med"},{"key":"8439_CR2","doi-asserted-by":"publisher","first-page":"977094","DOI":"10.3389\/fpubh.2022.977094","volume":"10","author":"S Lei","year":"2022","unstructured":"Lei S, Li X, Zhao H, Xie Y, Li J. Prevalence of sepsis among adults in China: a systematic review and meta-analysis. Front Public Health. 2022;10:977094. https:\/\/doi.org\/10.3389\/fpubh.2022.977094.","journal-title":"Front Public Health"},{"key":"8439_CR3","doi-asserted-by":"publisher","first-page":"654708","DOI":"10.1155\/2013\/654708","volume":"2013","author":"E Bassi","year":"2013","unstructured":"Bassi E, Park M, Azevedo LCP. Therapeutic strategies for high-dose vasopressor-dependent shock. Crit Care Res Pract. 2013;2013:654708. https:\/\/doi.org\/10.1155\/2013\/654708.","journal-title":"Crit Care Res Pract"},{"issue":"1","key":"8439_CR4","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s13054-018-2144-4","volume":"22","author":"P Nandhabalan","year":"2018","unstructured":"Nandhabalan P, Ioannou N, Meadows C, Wyncoll D. Refractory septic shock: our pragmatic approach. Crit Care. 2018;22(1):215. https:\/\/doi.org\/10.1186\/s13054-018-2144-4.","journal-title":"Crit Care"},{"issue":"9588","key":"8439_CR5","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/S0140-6736(07)61317-8","volume":"370","author":"M Singer","year":"2007","unstructured":"Singer M. Catecholamine treatment for shock\u2013equally good or bad? Lancet. 2007;370(9588):636\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)61317-8.","journal-title":"Lancet"},{"issue":"4","key":"8439_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/cc10245","volume":"15","author":"M Singer","year":"2011","unstructured":"Singer M, Matthay MA. Clinical review: Thinking outside the box\u2013an iconoclastic view of current practice. Crit Care. 2011;15(4):225. https:\/\/doi.org\/10.1186\/cc10245.","journal-title":"Crit Care"},{"issue":"9","key":"8439_CR7","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1007\/s12325-020-01422-x","volume":"37","author":"F Puntillo","year":"2020","unstructured":"Puntillo F, Giglio M, Pasqualucci A, Brienza N, Paladini A, Varrassi G. Vasopressor-sparing action of methylene blue in severe sepsis and shock: a narrative review. Adv Ther. 2020;37(9):3692\u2013706. https:\/\/doi.org\/10.1007\/s12325-020-01422-x.","journal-title":"Adv Ther"},{"issue":"6","key":"8439_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.annemergmed.2011.02.025","volume":"58","author":"DH Jang","year":"2011","unstructured":"Jang DH, Nelson LS, Hoffman RS. Methylene blue in the treatment of refractory shock from an amlodipine overdose. Ann Emerg Med. 2011;58(6):565\u20137. https:\/\/doi.org\/10.1016\/j.annemergmed.2011.02.025.","journal-title":"Ann Emerg Med"},{"issue":"3","key":"8439_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0006-2952(91)90311-r","volume":"42","author":"SC Salaris","year":"1991","unstructured":"Salaris SC, Babbs CF, Voorhees WD. Methylene blue as an inhibitor of superoxide generation by xanthine oxidase. A potential new drug for the attenuation of ischemia\/reperfusion injury. Biochem Pharmacol. 1991;42(3):499\u2013506. https:\/\/doi.org\/10.1016\/0006-2952(91)90311-r.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"8439_CR10","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1161\/01.res.74.6.1121","volume":"74","author":"JF Keaney","year":"1994","unstructured":"Keaney JF, Puyana JC, Francis S, Loscalzo JF, Stamler JS, Loscalzo J. Methylene blue reverses endotoxin-induced hypotension. Circ Res. 1994;74(6):1121\u20135. https:\/\/doi.org\/10.1161\/01.res.74.6.1121.","journal-title":"Circ Res"},{"issue":"10","key":"8439_CR11","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","volume":"29","author":"MY Kirov","year":"2001","unstructured":"Kirov MY, Evgenov OV, Evgenov NV, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study. Crit Care Med. 2001;29(10):1860\u20137. https:\/\/doi.org\/10.1097\/00003246-200110000-00002.","journal-title":"Crit Care Med"},{"issue":"2","key":"8439_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3904\/kjim.2005.20.2.123","volume":"20","author":"BK Park","year":"2005","unstructured":"Park BK, Shim TS, Lim CM, et al. The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock. Korean J Intern Med. 2005;20(2):123\u20138. https:\/\/doi.org\/10.3904\/kjim.2005.20.2.123.","journal-title":"Korean J Intern Med"},{"issue":"4","key":"8439_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.niox.2010.01.006","volume":"22","author":"NP Juffermans","year":"2010","unstructured":"Juffermans NP, Vervloet MG, Daemen-Gubbels CRG, Binnekade JM, de Jong M, Groeneveld ABJ. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock. Nitric Oxide. 2010;22(4):275\u201380. https:\/\/doi.org\/10.1016\/j.niox.2010.01.006.","journal-title":"Nitric Oxide"},{"issue":"2","key":"8439_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00003246-199502000-00010","volume":"23","author":"JC Preiser","year":"1995","unstructured":"Preiser JC, Lejeune P, Roman A, et al. Methylene blue administration in septic shock: a clinical trial. Crit Care Med. 1995;23(2):259\u201364. https:\/\/doi.org\/10.1097\/00003246-199502000-00010.","journal-title":"Crit Care Med"},{"issue":"1","key":"8439_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13054-023-04397-7","volume":"27","author":"M Ibarra-Estrada","year":"2023","unstructured":"Ibarra-Estrada M, Kattan E, Aguilera-Gonz\u00e1lez P, et al. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care. 2023;27(1):110. https:\/\/doi.org\/10.1186\/s13054-023-04397-7.","journal-title":"Crit Care"},{"key":"8439_CR16","unstructured":"Xiong X, Jin L, Wang L, Zhu T, Peng Y, Lin L. Effect of methylene blue on oxygen metabolism in patients with septic shock. Chin J Anesthesiol. Published online 2010:1239\u20131242."},{"issue":"10","key":"8439_CR17","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1097\/00003246-200210000-00015","volume":"30","author":"A Donati","year":"2002","unstructured":"Donati A, Conti G, Loggi S, et al. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? Crit Care Med. 2002;30(10):2271\u20137. https:\/\/doi.org\/10.1097\/00003246-200210000-00015.","journal-title":"Crit Care Med"},{"issue":"11","key":"8439_CR18","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3760\/cma.j.issn.0376-2491.2019.11.015","volume":"99","author":"Y Lu","year":"2019","unstructured":"Lu Y, Yu H, Liu Q, Yao M, Zhu J. Efficacy of methylene blue continuous intravenous infusion in patients with septic shock. Natl Med J China. 2019;99(11):868\u201371. https:\/\/doi.org\/10.3760\/cma.j.issn.0376-2491.2019.11.015.","journal-title":"Natl Med J China"},{"issue":"6","key":"8439_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/0310057X0203000606","volume":"30","author":"D Memis","year":"2002","unstructured":"Memis D, Karamanlioglu B, Yuksel M, Gemlik I, Pamukcu Z. The influence of methylene blue infusion on cytokine levels during severe sepsis. Anaesth Intensive Care. 2002;30(6):755\u201362. https:\/\/doi.org\/10.1177\/0310057X0203000606.","journal-title":"Anaesth Intensive Care"},{"issue":"3","key":"8439_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137. https:\/\/doi.org\/10.7326\/0003-4819-158-3-201302050-00583.","journal-title":"Ann Intern Med"},{"key":"8439_CR21","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. https:\/\/doi.org\/10.1136\/bmj.c332.","journal-title":"BMJ"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08439-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-024-08439-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-024-08439-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T17:03:16Z","timestamp":1727456596000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-024-08439-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["8439"],"URL":"https:\/\/doi.org\/10.1186\/s13063-024-08439-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3454540\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"25 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the Ethics Committee of General Hospital of Southern Theatre Command. The approval number is NZLLKZ2022183. Written, informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0{24}"}},{"value":"We are willing to provide a model consent form and other related documentation on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication\u00a0{32}"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0{28}"}}],"article-number":"630"}}